메뉴 건너뛰기




Volumn 25, Issue 7, 2013, Pages 446-447

Cardiac Toxicity Monitoring for HER2-positive Breast Cancer Patients Undergoing Trastuzumab Therapy: Are We Doing Enough?

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

EID: 84878626758     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.03.006     Document Type: Letter
Times cited : (3)

References (7)
  • 1
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEngl J Med 2001, 344:783-792.
    • (2001) NEngl J Med , vol.344 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3
  • 2
    • 34548531901 scopus 로고    scopus 로고
    • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    • Suter T.M., Procter M., van Veldhuisen D.J., et al. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. JClin Oncol 2007, 25:3859-3865.
    • (2007) JClin Oncol , vol.25 , pp. 3859-3865
    • Suter, T.M.1    Procter, M.2    van Veldhuisen, D.J.3
  • 3
    • 61749084637 scopus 로고    scopus 로고
    • Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
    • Jones A.L., Barlow M., Barrett-Lee P.J., et al. Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring. Br J Cancer 2009, 100:684-692.
    • (2009) Br J Cancer , vol.100 , pp. 684-692
    • Jones, A.L.1    Barlow, M.2    Barrett-Lee, P.J.3
  • 4
    • 84878653787 scopus 로고    scopus 로고
    • British Society of Echocardiography Council Position Statement. The evaluation of left ventricular function for patients being considered or receiving trastuzumab (Herceptin) therapy
    • British Society of Echocardiography Council Position Statement. The evaluation of left ventricular function for patients being considered or receiving trastuzumab (Herceptin) therapy. Available at: . http://cdn1.cache.twofourdigital.net/u/bsecho/media/13210/trastuzumab_statement.pdf.
  • 5
    • 80051624730 scopus 로고    scopus 로고
    • Can a teaching intervention reduce interobserver variability in LVEF assessment: a quality control exercise in the echocardiography lab
    • Johri A.M., Picard M.H., Newell J., Marshall J.E., King M.E., Hung J. Can a teaching intervention reduce interobserver variability in LVEF assessment: a quality control exercise in the echocardiography lab. JACC Cardiovasc Imaging 2011, 4:821-829.
    • (2011) JACC Cardiovasc Imaging , vol.4 , pp. 821-829
    • Johri, A.M.1    Picard, M.H.2    Newell, J.3    Marshall, J.E.4    King, M.E.5    Hung, J.6
  • 6
    • 29244432482 scopus 로고    scopus 로고
    • Recommendation for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group
    • Lang R.M., Bierig M., Devereux R.B., et al. Recommendation for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group. JAm Soc Echocardiogr 2005, 18:1440-1463.
    • (2005) JAm Soc Echocardiogr , vol.18 , pp. 1440-1463
    • Lang, R.M.1    Bierig, M.2    Devereux, R.B.3
  • 7
    • 84877993046 scopus 로고    scopus 로고
    • Senior R on behalf of the British Society of Echocardiography. Implementation of echocardiographic contrast agents into clinical practice: a United Kingdom National Health Service Survey on behalf of the British Society of Echocardiography
    • [Epub ahead of print]
    • Bhattacharyya S., Khattar R., Lloyd G. Senior R on behalf of the British Society of Echocardiography. Implementation of echocardiographic contrast agents into clinical practice: a United Kingdom National Health Service Survey on behalf of the British Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2012, [Epub ahead of print]. http://dx.doi.org/10.1093/ehjci/jes212.
    • (2012) Eur Heart J Cardiovasc Imaging
    • Bhattacharyya, S.1    Khattar, R.2    Lloyd, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.